Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
850.6 DKK
-2.58%
Market Closed
Updated:
May 6, 2024
Novo Nordisk A/S
Operating Expenses
|
Novo Nordisk A/S
Operating Expenses Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Operating Expenses
-kr91.8B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-9%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Operating Expenses
-kr12.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Operating Expenses
-kr2.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Operating Expenses?
Operating Expenses
-91.8B
DKK
-91.8B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Operating Expenses amounts to -91.8B DKK.
What is Novo Nordisk A/S's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-9%
-9%
Over the last year, the Operating Expenses growth was -26%. The average annual Operating Expenses growth rates for Novo Nordisk A/S have been -21% over the past three years , -14% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
